SEI INVESTMENTS CO - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$24,695
-62.5%
41,185
-18.6%
0.00%
Q2 2023$65,796
+57.6%
50,618
+113.4%
0.00%
Q1 2023$41,742
-35.9%
23,721
+14.3%
0.00%
Q4 2022$65,154
-36.1%
20,745
-0.5%
0.00%
Q3 2022$102,000
+67.2%
20,843
+1.0%
0.00%
Q1 2022$61,000
-37.8%
20,635
+1.5%
0.00%
Q4 2021$98,000
-33.8%
20,336
-2.5%
0.00%
Q3 2021$148,000
-42.0%
20,848
+2.0%
0.00%
-100.0%
Q2 2021$255,000
-31.3%
20,436
-1.9%
0.00%0.0%
Q1 2021$371,0000.0%20,8290.0%0.00%0.0%
Q4 2020$371,000
-65.3%
20,829
-80.8%
0.00%
-66.7%
Q3 2020$1,069,000
+65.0%
108,395
+63.5%
0.00%
+50.0%
Q2 2020$648,000
+142.7%
66,288
+107.8%
0.00%
+100.0%
Q4 2019$267,000
+8800.0%
31,904
+16603.7%
0.00%
Q4 2018$3,0000.0%1910.0%0.00%
Q3 2018$3,000
+50.0%
191
+59.2%
0.00%
Q2 2018$2,000
-93.5%
120
-97.6%
0.00%
Q1 2016$31,000
-31.1%
5,049
+3.3%
0.00%
Q4 2015$45,000
-92.5%
4,889
-95.4%
0.00%
-100.0%
Q3 2015$597,000
+180.3%
105,778
+452.5%
0.01%
+150.0%
Q2 2015$213,000
-40.2%
19,145
-15.8%
0.00%
-33.3%
Q1 2015$356,000
+16.0%
22,727
+12.5%
0.00%0.0%
Q4 2014$307,00020,2040.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders